Evidence map›Paper›PMID 31792954›Full record

ReviewImmunology2020

The IFITM protein family in adaptive immunity.

Diana C Yánez, Susan Ross, Tessa Crompton

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04734470 (Expression of CD19 Complex in Lymphoproliferative Disorders), which is not on this map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04734470 unknown statusnot on this mapstarted 2021, after this paper: background citation

Expression of CD19 Complex in Lymphoproliferative Disorders

TypeobservationalSponsorAssiut UniversityRan2021 to 2023Enrolled92ConditionsLymphoproliferative DisordersArmsFlow cytometry
3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 156 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Diana C YánezUCL Great Ormond Street Institute of Child Health, London, UK.
Susan RossUCL Great Ormond Street Institute of Child Health, London, UK.
Tessa CromptonUCL Great Ormond Street Institute of Child Health, London, UK.ORCID 0000-0002-8973-4021
Great Ormond Street Hospital · GB

Funding

Medical Research Council MR/P000843/1
6 · The paper itself

Abstract

Interferon-inducible transmembrane (IFITM) proteins are a family of small homologous proteins, localized in the plasma and endolysosomal membranes, which confer cellular resistance to many viruses. In addition, several distinct functions have been associated with different IFITM family members, including germ cell specification (IFITM1-IFITM3), osteoblast function and bone mineralization (IFITM5) and immune functions (IFITM1-3, IFITM6). IFITM1-3 are expressed by T cells and recent experiments have shown that the IFITM proteins are directly involved in adaptive immunity and that they regulate CD4

Indexed as

Adaptive ImmunityAnimalsAntigens, DifferentiationAsthmaCell DifferentiationCell MembraneEndosomesGene Expression RegulationHumansInflammationMiceProtein IsoformsSignal TransductionTh1 CellsTh2 CellsVirus DiseasesAntigens, Differentiationleu-13 antigenProtein Isoformsdifferentiationinterferon-inducible transmembrane proteinT cellT helper type 1T helper type 2

Identifiers

PMID31792954
PMCPMC7078001
OpenAlexW2993314609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.